PRI-100(PRI-100) - 药物靶点：α-synuclein_在研适应症：家族性1型帕金森病_专利_临床

概要

基本信息

药物类型

合成多肽

别名

靶点

α-synuclein

作用机制

α-synuclein抑制剂(α-突触核蛋白抑制剂)

治疗领域

神经系统疾病内分泌与代谢疾病

在研适应症

家族性1型帕金森病

非在研适应症-

原研机构

Priavoid GmbH

在研机构

Priavoid GmbH

非在研机构-

最高研发阶段临床前

首次获批日期-

最高研发阶段(中国)-

特殊审评-

关联

100 项与 PRI-100 相关的临床结果

登录后查看更多信息

100 项与 PRI-100 相关的转化医学

登录后查看更多信息

100 项与 PRI-100 相关的专利（医药）

登录后查看更多信息

1

项与 PRI-100 相关的文献（医药）

1978-10-01·Journal of Clinical Psychology3区 · 心理学

Personality characteristisc of the female alcoholic

3区 · 心理学

Article

作者: Mary Alice Herzog ; Arthur S. Wilson

Utilized the Personal Reaction Inventory (PRI-100) on a sample of 47 hospitalized female alcoholics and a control group of 47 individually matched nonalcoholic Ss. A measure of drinking behavior was established by the Volume Variability Index (V/V) administered to each S immediately prior to the administration of the PRI-100. A test-retest experimental design over a 2-week period yielded an average reliability coefficient of .88 for the PRI-100. The findings show that the personality characteristics associated with Assertive Antisocial Behavior, one of the factors of the PRI-100, are valuable predictors of drinking behavior. The two other personality factors of the PRI-100, Lack of Order and Lively Social Presence, were found to be unrelated to drinking behavior and therefore inadequate predictors.

100 项与 PRI-100 相关的药物交易

登录后查看更多信息